The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Calithera Biosciences
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Jounce Therapeutics (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Prometheus (Inst)
Overall survival (OS) by clinical risk category for high dose interleukin-2 (HD IL-2) treated metastatic renal cell cancer (RCC): Data from PROCLAIM.
 
Mayer N. Fishman
Consulting or Advisory Role - Novartis; Pfizer; Pfizer
Speakers' Bureau - Exelixis; Ipsen; Medivation
Research Funding - Acceleron Pharma (Inst); Alkermes (Inst); Argos Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Merck (Inst); Merck (Inst); Nektar (Inst); Pfizer (Inst); Prometheus (Inst)
 
Joseph I Clark
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Argos Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Nektar (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche (I)
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; Eisai; Roche
Speakers' Bureau - AstraZeneca
Research Funding - Acerta Pharma (Inst); ARIAD (Inst); AstraZeneca (Inst); Bayer (Inst); BIND Biosciences (Inst); BIND Biosciences (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); United Biosource Corporation (Inst)
 
Brendan D. Curti
Consulting or Advisory Role - Alligator Bioscience; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Prometheus
 
Neeraj Agarwal
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cerulean Pharma; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genentech/Roche; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Ralph J. Hauke
Stock and Other Ownership Interests - Aethlon
Honoraria - Best Doctors, Inc
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pharmacyclics (Inst); SOTIO (Inst); US Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending on an immunotherapeutic
Other Relationship - ABIM Subspecialty Board
 
Kathleen Margaret Mahoney
Consulting or Advisory Role - Jefferies
Patents, Royalties, Other Intellectual Property - HHLA2 monoclonal antibodies to block the interaction with the receptor for potential therapeutics
 
Helen Moon
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Prometheus
 
Jonathan Treisman
No Relationships to Disclose
 
Scott Tykodi
No Relationships to Disclose
 
Gregory A. Daniels
Consulting or Advisory Role - Merck
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Viralytics (Inst)
 
Michael Morse
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Ipsen; Lexicon; Merck; Novartis; Taiho Pharmaceutical
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Merck (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Michael K.K. Wong
Consulting or Advisory Role - Merck; Pfizer
 
Howard Kaufman
Employment - Replimune
Honoraria - EMD Serono; SapVax
Consulting or Advisory Role - EMD Serono; SapVax
 
Nancy C. Gregory
Employment - Prometheus
 
Janice P. Dutcher
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Medarex; Eisai; Merck; Nektar; Prometheus; TRACON Pharma
Speakers' Bureau - Exelixis; Prometheus
Travel, Accommodations, Expenses - Exelixis; Prometheus